Trulieve is an industry-leading, vertically integrated cannabis company and multi-state operator in the United States. As the first and largest fully licensed medical cannabis company in Florida, Trulieve operates a seed-to-sale model, cultivating and producing all products in-house before distributing them through a network of branded dispensaries across multiple states. The company is publicly traded on the Canadian Securities Exchange (TRUL) and OTCQX Best Market (TCNNF), demonstrating its position as a major player in the U.S. cannabis market.
Trulieve's product portfolio is designed to alleviate seizures, severe and persistent muscle spasms, pain, nausea, loss of appetite, and other symptoms associated with serious medical conditions such as cancer. The company offers both low-THC/CBD products for non-euphoric care and traditional cannabis products. With established operations in states including Florida, Arizona, Pennsylvania, and Massachusetts, Trulieve has generated over $1.2 billion in annual revenue and continues expanding its market presence through strategic acquisitions and organic growth.